FDMT

FDMT Cost of Revenue

$53.36MTTM · USD

Period ending:

FDMT FY Cost of RevenueUSD
FDMT FY Cost of Revenue2017-12-31: $13.57M2018-12-31: $18.36M2019-12-31: $38.72M2020-12-31: $53.04M2021-12-31: $61.36M2022-12-31: $80.25M2023-12-31: $97.10M2024-12-31: $141.30M2025-12-31: $7.63M$141.30M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

FDMT cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

4D Molecular Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
7,625,000
141,299,000
97,096,000
80,253,000
61,360,000
53,038,000
38,718,000
18,362,000
13,573,000

Compare cost of revenue

All FDMT financial metrics · FDMT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.